2025. PHARMACOKINETICS AND MOLECULAR DOCKING-BASED INVESTIGATION OF BIOACTIVE COMPOUNDS FROM Curcuma longa TARGETING KEY PROTEINS IN LOW BACK PAIN MANAGEMENT. The Research of Medical Science Review. 3, 8 (Aug. 2025), 164–182.